03.03.2017 Views

Management of HCV G4 Kasr Alainy

How would you treat HCV genotype 4 in 2017

How would you treat HCV genotype 4 in 2017

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Conclusion<br />

• Treatment <strong>of</strong> <strong>HCV</strong> <strong>G4</strong> has become very effective<br />

• Most regimens <strong>of</strong> DAAs associated with high SVR rates<br />

(>90%): SOF +: LDV, VEL, SMV, DAC; PAR-r-OMB, GZR+EBR<br />

• Real-life data with several regimens confirmed high SVR<br />

rates in clinical trials<br />

• Shorter duration treatment (8 weeks) coming soon<br />

• Generic DAAs effective

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!